Ipca Laboratories Stock (NSE:IPCALAB)

INDIA |NSE |INR

Price
INR 1,043.15
Change
0.17%
Today's Range
INR1,037.00 - INR1,052.20
52-Week Range
INR925.20 - INR1,377.65
Market Cap
INR264.65B
Volume
305.51K

About Ipca Laboratories (NSE:IPCALAB)

(NSE:IPCALAB) Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. The company offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. It also provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic, cardiology, dermatology, diabetes, fever, gastroenterology, hematology, helminthics, hepatoprotective, immunosuppressant, infectious disease, malarial, neurology, nutraceuticals, ophthalmology, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology, as well as products in various dosage forms comprising oral solids, powders for suspension, and liquid and dry injections. The company exports its products to approximately 100 countries worldwide. It has an agreement with Medicines for Malaria Venture to develop a novel antimalarial co-formulation named Atoguanil. The company was incorporated in 1949 and is based in Mumbai, India.
Show more

IPCALAB Stock Price

Statistics Highlights (NSE:IPCALAB)

Shares Outstanding 253.70M Beta 0.04
Public Float 134.65M P/E Ratio 28.92
% Short of Float - Dividend (Yield) 4.00 (0.01%)
Held by Insiders 46.70% Ex-Dividend Date Nov 22, 2021
Held by Institutions 37.76% IPO Date -

IPCALAB Financial Summary

|
Mar 21 Mar 20 Mar 19
Revenue INR53.41B INR45.59B INR36.92B
EBITDA INR15.98B INR9.68B INR7.50B
Net Income INR11.40B INR6.06B INR4.45B
Total Assets INR60.68B INR52.60B INR45.51B
Total Cash INR1.66B INR584.60M INR2.81B
Total Debt INR2.65B INR5.01B INR4.65B
Dec 21 Sep 21 Jun 21
Revenue INR14.30B INR15.44B INR15.66B
EBITDA INR3.21B INR3.76B INR4.35B
Net Income INR1.97B INR2.50B INR3.07B
Total Assets INR INR68.34B INR
Total Cash INR INR1.58B INR
Total Debt INR INR3.07B INR

IPCALAB Stock Price History

Ipca Laboratories Annual Stock Price History

Year Open Close Change
2021 INR2122.00 INR1043.15 -50.84%
2021 INR2196.00 INR2122.00 -3.37%
2020 INR1136.90 INR2196.00 93.16%

Ipca Laboratories Daily Stock Price History

Date Open High Low Close Change Volume
Jun 17, 2022 INR860.00 INR871.30 INR845.00 INR866.20 0.06% 253.37K
Jun 14, 2022 INR864.45 INR870.25 INR856.60 INR865.65 -0.37% 237.44K
Jun 9, 2022 INR865.80 INR872.95 INR862.25 INR868.85 0.89% 130.21K

(NSE:IPCALAB) Stock Price FAQs

What is today's stock price of Ipca Laboratories (NSE:IPCALAB)?

  • The current stock price of Ipca Laboratories (NSE:IPCALAB) is INR1043.15.
  • Today IPCALAB stock price opened at INR1048.00 after previous close of INR1041.35.
  • During the day, Ipca Laboratories stock quote has varied from a low of INR1037.00 to a high of INR1052.20.

What is Ipca Laboratories's 52-week change?

  • IPCALAB 52-week high stock quote is INR1377.65, which is 32.10% above the current share price.
  • The Ipca Laboratories (NSE:IPCALAB) 52-week low stock price is INR925.20, which is 11.30% below the current share price.
  • Ipca Laboratories share price volatility (52-week beta) is 0.04.

Ipca Laboratories (NSE:IPCALAB) FAQ

How Much is Ipca laboratories Worth?

Ipca laboratories's worth today based on market capitalisation is INR264.65B

How much dividend does Ipca laboratories Pay?

The current annualized dividend payout for IPCALAB stock is INR8.00, the dividend yield is 0.77% and the payout ratio is 9.87%.
View More Details on Ipca laboratories's "Dividend" Section

What is Ipca laboratories’s Price to Earning (PE) ratio?

Ipca laboratories has a Price to Earning (P/E) ratio of 28.92. IPCALAB stock also has a Price to Sales (P/S) ratio of 4.68.

What is the Ipca laboratories's ticker?

Ipca laboratories trades on the NSE stock market in India under the ticker symbol "IPCALAB". Ipca laboratories’s stock symbol can also be displayed as "NSE:IPCALAB".

Who are the owners of Ipca laboratories?

Ipca laboratories (NSE:IPCALAB) is owned by 37.76% institutional shareholders and by 46.70% insiders. The rest is owned by the public.
Explore More Details on Ipca laboratories's “Ownership” Section

Who are the key executives of Ipca laboratories (IPCALAB)?

Ipca laboratories's key executive team includes the following managers:

  • Mr. Premchand Godha A.C. A., B. Com., CA, Chairman, CEO & MD (1946)
  • Mr. Ajit Kumar Bhanwarlal Jain, CFO, Joint MD & Exec. Director (1955)
  • Mr. Harish P. Kamath, Compliance Officer, Corp. Counsel & Company Sec. (1959)
  • Mr. Pranay Godha, Exec. Director (1972)
  • Mr. Prashant P. Godha, Exec. Director (1975)
  • Mr. Pawan Kothari, VP of Operations (1965)
  • Mr. Vishnu Saran Singh Kushwaha, VP of Technical (1968)
  • Mr. Sunil Ghai, Pres of Marketing (1963)
  • Mr. Sameer S. Tamhane, Sr. VP of HR (1967)
  • Dr. Ashok Kumar, Pres of R&D - Chemicals (1954)

What is Ipca laboratories’s Sector & Industry Classification?

Ipca laboratories (NSE:IPCALAB) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.

How many employees work for Ipca laboratories?

Currently the number of employees working for Ipca laboratories is 14,574.

Where are Ipca laboratories's Headquarters?

Ipca laboratories (NSE:IPCALAB) is headquartered in India.

What are Ipca laboratories's Address and Phone Number?

Ipca laboratories’s mailing address is 125, Kandivli Industrial Estate, Mumbai, India, 400067.
The company’s phone number is 91 22 6210 5000.

What is the official website for Ipca laboratories?

Ipca laboratories’s official website is http://www.ipca.com